EFFECTS OF EXERCISE AND LIRAGLUTIDE ON VASCULAR HEALTH AND INFLAMMATION DURING WEIGHT LOSS MAINTENANCE: A PRESPECIFIED SECONDARY ANALYSIS OF THE S-LITE TRIAL

Descargar Publicación
Alenigliprón oral: pérdida de peso de hasta 12% en solo 36 semanas GLP-1 therapies for obesity: mechanisms, outcomes, and regulatory challenges